Cargando…
Radiation Proctitis and Management Strategies
Radiotherapy (RT) is a treatment modality that uses high-energy rays or radioactive agents to generate ionizing radiation against rapidly dividing cells. The main objective of using radiation in cancer therapy is to impair or halt the division of the tumor cells. Over the past few decades, advanceme...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Gastrointestinal Endoscopy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831406/ https://www.ncbi.nlm.nih.gov/pubmed/34788934 http://dx.doi.org/10.5946/ce.2020.288 |
_version_ | 1784648502240870400 |
---|---|
author | Dahiya, Dushyant Singh Kichloo, Asim Tuma, Faiz Albosta, Michael Wani, Farah |
author_facet | Dahiya, Dushyant Singh Kichloo, Asim Tuma, Faiz Albosta, Michael Wani, Farah |
author_sort | Dahiya, Dushyant Singh |
collection | PubMed |
description | Radiotherapy (RT) is a treatment modality that uses high-energy rays or radioactive agents to generate ionizing radiation against rapidly dividing cells. The main objective of using radiation in cancer therapy is to impair or halt the division of the tumor cells. Over the past few decades, advancements in technology, the introduction of newer methods of RT, and a better understanding of the pathophysiology of cancers have enabled physicians to deliver doses of radiation that match the exact dimensions of the tumor for greater efficacy, with minimal exposure of the surrounding tissues. However, RT has numerous complications, the most common being radiation proctitis (RP). It is characterized by damage to the rectal epithelium by secondary ionizing radiation. Based on the onset of signs and symptoms, post-radiotherapy RP can be classified as acute or chronic, each with varying levels of severity and complication rates. The treatment options available for RP are limited, with most of the data on treatment available from case reports or small studies. Here, we describe the types of RT used in modern-day medicine and radiation-mediated tissue injury. We have primarily focused on the classification, epidemiology, pathogenesis, clinical features, treatment strategies, complications, and prognosis of RP. |
format | Online Article Text |
id | pubmed-8831406 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Korean Society of Gastrointestinal Endoscopy |
record_format | MEDLINE/PubMed |
spelling | pubmed-88314062022-02-22 Radiation Proctitis and Management Strategies Dahiya, Dushyant Singh Kichloo, Asim Tuma, Faiz Albosta, Michael Wani, Farah Clin Endosc Review Radiotherapy (RT) is a treatment modality that uses high-energy rays or radioactive agents to generate ionizing radiation against rapidly dividing cells. The main objective of using radiation in cancer therapy is to impair or halt the division of the tumor cells. Over the past few decades, advancements in technology, the introduction of newer methods of RT, and a better understanding of the pathophysiology of cancers have enabled physicians to deliver doses of radiation that match the exact dimensions of the tumor for greater efficacy, with minimal exposure of the surrounding tissues. However, RT has numerous complications, the most common being radiation proctitis (RP). It is characterized by damage to the rectal epithelium by secondary ionizing radiation. Based on the onset of signs and symptoms, post-radiotherapy RP can be classified as acute or chronic, each with varying levels of severity and complication rates. The treatment options available for RP are limited, with most of the data on treatment available from case reports or small studies. Here, we describe the types of RT used in modern-day medicine and radiation-mediated tissue injury. We have primarily focused on the classification, epidemiology, pathogenesis, clinical features, treatment strategies, complications, and prognosis of RP. Korean Society of Gastrointestinal Endoscopy 2022-01 2021-11-18 /pmc/articles/PMC8831406/ /pubmed/34788934 http://dx.doi.org/10.5946/ce.2020.288 Text en Copyright © 2022 Korean Society of Gastrointestinal Endoscopy https://creativecommons.org/licenses/by-nc/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Dahiya, Dushyant Singh Kichloo, Asim Tuma, Faiz Albosta, Michael Wani, Farah Radiation Proctitis and Management Strategies |
title | Radiation Proctitis and Management Strategies |
title_full | Radiation Proctitis and Management Strategies |
title_fullStr | Radiation Proctitis and Management Strategies |
title_full_unstemmed | Radiation Proctitis and Management Strategies |
title_short | Radiation Proctitis and Management Strategies |
title_sort | radiation proctitis and management strategies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831406/ https://www.ncbi.nlm.nih.gov/pubmed/34788934 http://dx.doi.org/10.5946/ce.2020.288 |
work_keys_str_mv | AT dahiyadushyantsingh radiationproctitisandmanagementstrategies AT kichlooasim radiationproctitisandmanagementstrategies AT tumafaiz radiationproctitisandmanagementstrategies AT albostamichael radiationproctitisandmanagementstrategies AT wanifarah radiationproctitisandmanagementstrategies |